Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • CDC Confirms Second Case Of Monkeypox In US Citizen Traveling From Nigeria

    According to the Washington Post (11/17), “A Maryland resident who recently traveled to Nigeria contracted a case of the monkeypox virus, the Maryland Department of Health and the U.S. Centers for Disease Control and Prevention reported Tuesday.” The pers...
    Full Article
  • FBI, CDC Investigating Several Vials Labeled “Smallpox” That Were Found At Vaccine Research Facility

    USA Today (11/17, Gleeson) reports, “Several vials labeled as ‘smallpox’ were discovered at a Merck & Co. vaccine research facility near Philadelphia, prompting the FBI and Centers for Disease Control and Prevention to open investigations, according to th...
    Full Article
  • Risk For Hypertension Among Younger Adults With Perinatal HIV Infection Does Not Appear To Be Increased By Traditional, HIV-Related Risk Factors, Researchers Say

    Infectious Disease Advisor (11/17, van Paridon) reports that “the risk for hypertension among adults with perinatal HIV infection does not appear to be increased by most traditional or HIV-related risk factors, according to” researchers who “conducted a c...
    Full Article
  • Number Of New Diagnoses Of Acute Flaccid Myelitis Among Children Did Not Increase In 2020, Research Suggests

    Infectious Disease Advisor (11/17, Nye) reports that “in 2020, the number of new diagnoses of acute flaccid myelitis (AFM) did not increase as expected,” according to findings “published in the Morbidity and Mortality Weekly Report.” Investigators “conduc...
    Full Article
  • Overuse Of Antibiotics During COVID-19 Pandemic Fueling Drug-Resistant Infections, Pan American Health Organization Warns

    Reuters (11/17, Boadle) reports, “Overuse of antibiotics and other antimicrobial drugs during the coronavirus pandemic is helping bacteria develop resistance that will render these important medicines ineffective over time, the Pan American Health Organiz...
    Full Article
  • US Health Officials Warn Of Increasing Hospitalizations Among People Fully Vaccinated Against COVID-19

    On its website, NBC News (11/17, Syal) reports that as COVID-19 infections “rise throughout the U.S., health officials warn that an increasing number of fully vaccinated people are being hospitalized or going to the emergency room.” NIAID Director Dr. Ant...
    Full Article
  • Vir Biotechnology CEO Says Its COVID-19 Treatment “Stands Up Well” To All Virus Variants

    CNBC (11/17, Towey) reports “a monoclonal antibody Covid treatment from Vir Biotechnology and GlaxoSmithKline ‘stands up well’ to all variants of the virus, Vir President and CEO George Scangos” said Wednesday. The comments “came after the two companies a...
    Full Article
  • Administration To Invest Billions To Expand US COVID-19 Vaccine Manufacturing Capabilities

    The Washington Post (11/17, Pager, Diamond) reports, “The Biden administration is planning to invest billions of dollars to expand U.S. manufacturing capabilities of coronavirus vaccines to increase the supply of doses for poorer nations and better prepar...
    Full Article
  • Moderna Requests FDA Emergency Authorization For COVID-19 Booster Shots For All Adults

    The Hill (11/17, Coleman) reports that “Moderna has submitted a request to the Food and Drug Administration (FDA) to authorize booster doses of its coronavirus vaccine for all adults.” The company “announced that it asked the FDA to allow the 71 million a...
    Full Article
  • Nearly 10% Of Kids Aged 5 To 11 Have Received First COVID-19 Vaccine Dose, White House Estimates

    The New York Times (11/17, Stolberg) reports, “The pace of vaccination against the coronavirus among newly eligible younger children is accelerating, and nearly 10 percent of the nation’s 5- to 11-year olds have already had their first shot, the White Hou...
    Full Article
  • Pfizer Agrees To Grant Drugmakers License To Make COVID-19 Antiviral In Lower-Income Countries

    The New York Times (11/16, Nolen, Robbins) reports, “Pfizer announced a deal on Tuesday to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population.” The deal “...
    Full Article
  • Despite Industry Setbacks, Companies Still Strive Toward Breakthroughs In Blood-Testing Technology

    The Washington Post (11/16, Lerman) reports Theranos’ trouble with blood-testing technology and experts’ warnings over the difficulty in utilizing the technology “hasn’t stopped a new generation of founders from attempting to make breakthroughs in less in...
    Full Article
  • Many People Who Use Drugs Who Are Sent To Skilled Nursing Facilities For OPAT Do Not Complete Treatment, Study Indicates

    Healio (11/16, Stulpin) reports, “Many people who use drugs [PWUD] who are sent to skilled nursing facilities for outpatient parenteral antibiotic therapy [OPAT] do not complete treatment, according to findings from a single-center study.” Furthermore, in...
    Full Article
  • Researchers Identify Second Person Who May Have Achieved Sterilizing Cure Of HIV Infection

    The Washington Post (11/16, Iati) reports, “A 30-year-old Argentine woman appears to have become the second documented person whose body may have eliminated her HIV on its own, a study says.” HealthDay (11/16, Norton) reports that “researchers have identi...
    Full Article
  • Pfizer Requests Emergency Authorization For Five-Day COVID-19 Drug Regimen

    The Washington Post (11/16, Johnson) reports Pfizer “requested emergency authorization Tuesday for its five-day antiviral” treatment “regimen, [PF-07321332] Paxlovid, making it the second easy-to-take treatment aimed at keeping newly infected people out o...
    Full Article
  • Administration Reportedly Planning To Purchase 10M Courses Of Pfizer’s COVID-19 Drug

    The Washington Post (11/16, A1, Pager, McGinley) reports “the Biden administration is planning to purchase 10 million courses of Pfizer’s” COVID-19 treatment under a $5 billion deal, “according to two people with knowledge of the transaction.” The company...
    Full Article
  • Unstable Housing, Homelessness Tied To Heightened Risk Of COVID-19 Re-Infection, Study Suggests

    PatientEngagementHIT (11/16, Rodriguez) reports research “suggests that unstable housing and homelessness are associated with a heightened risk of COVID-19 re-infection.” Investigators “looked at EHR data from Boston Medical Center for positive COVID-19 p...
    Full Article
  • CDC Adds Four European Destinations To Highest-Risk Travel Category

    The Washington Post (11/16, Timsit) reports that on Monday, the Centers for Disease Control and Prevention “moved four European destinations to its highest-risk category for travel – a reflection of growing concern over rising [COVID-19] cases in Europe j...
    Full Article
  • FDA Aiming To Authorize Pfizer-BioNTech COVID-19 Vaccine Boosters For All Adults As Early As Thursday

    The New York Times (11/16, Weiland, LaFraniere) reports, “The Food and Drug Administration is aiming to authorize booster doses of Pfizer-BioNTech’s coronavirus vaccine for all adults as early as Thursday...according to people familiar with the agency’s p...
    Full Article
  • CDC Vaccine Advisory Panel To Discuss Expanding Pfizer COVID-19 Booster Eligibility To All Adults Friday

    The AP (11/16, Stobbe) reports the CDC’s Advisory Committee on Immunization Practices “will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weeke...
    Full Article
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id